What Are the Risks of Investing in Cannabis Stocks?

Cannabis investing carries a unique set of risks that distinguish it from most other sectors. Understanding these risks is essential before allocating capital to cannabis stocks, regardless of how compelling the growth narrative may appear.

The most fundamental risk is federal illegality. Despite being legal in numerous states, cannabis remains a Schedule I controlled substance under federal law. This creates a cascade of problems: companies cannot list on major exchanges (limiting investor access and liquidity), cannot deduct ordinary business expenses under Section 280E (crushing profitability), cannot access traditional banking services (forcing cash-heavy operations), and face the theoretical risk of federal enforcement action. While federal prosecution of state-legal operators has been rare, the legal uncertainty creates a persistent overhang.

Share dilution is one of the most overlooked risks in cannabis investing. Because cannabis companies have limited access to traditional debt financing, they frequently raise capital by issuing new shares or convertible notes. Many MSOs have increased their share counts by 50-200% over the past few years, significantly eroding per-share value even as revenue grows. Investors should carefully monitor shares outstanding and dilution rates, which CannaCap tracks in our rankings.

Market and operational risks are also substantial. Oversupply in mature cannabis markets has driven wholesale flower prices down by 50-80% in states like Oregon and Colorado. Illicit market competition remains fierce, particularly in states with high tax and regulatory burdens. Individual companies face execution risks around multi-state expansion, retail buildouts, and inventory management in a product with limited shelf life.

Liquidity risk is a practical concern for cannabis investors. Most US MSO stocks trade on OTC Markets with relatively low daily trading volume and wide bid-ask spreads. This can make it difficult to enter or exit positions at desired prices, particularly during volatile periods. Large orders can move prices significantly, and stop-loss orders may execute far from the intended price.

Finally, political and regulatory risk cuts both ways. While legalization progress could catalyze major upside, regulatory setbacks — such as failed legalization votes, increased enforcement, or unfavorable rescheduling outcomes — can trigger sharp selloffs. State-level regulatory changes, including moratoriums on new licenses, changes in tax structures, or shifts in enforcement priorities, can also materially impact individual companies and markets.